To provide information to prescribers in Federally qualified health centers and facilities of the Indian Health Service on best practices for prescribing naloxone.

1/11/2023, 1:31 PM

Congressional Summary of HR 4983

This bill requires the Department of Health and Human Services to provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing naloxone (a prescription drug used to rapidly reverse an opioid overdose) for patients a provider identifies as having an elevated risk of opioid overdose. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 4983

Bill HR 4983 is currently in the status of Bill Introduced since April 18, 2016. Bill HR 4983 was introduced during Congress 114 and was introduced to the House on April 18, 2016. Bill HR 4983's most recent activity was Referred to the Subcommittee on Indian, Insular and Alaska Native Affairs. as of April 27, 2016

Bipartisan Support of Bill HR 4983

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 4983

Primary Policy Focus

Health

Potential Impact Areas

- Drug trafficking and controlled substances

- Drug, alcohol, tobacco use

- Health information and medical records

- Health promotion and preventive care

- Indian social and development programs

- Minority health

- Prescription drugs

Alternate Title(s) of Bill HR 4983

To provide information to prescribers in Federally qualified health centers and facilities of the Indian Health Service on best practices for prescribing naloxone.